European Journal of Rheumatology
Original Article

Demographic, clinical, and laboratory features of Turkish patients with gouty arthritis: A prospective cohort study


Department of Rheumatology, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Turkey


Department of Rheumatology, Koç University School of Medicine, İstanbul, Turkey

Eur J Rheumatol 2019; 6: 1-6
DOI: 10.5152/eurjrheum.2018.18149
Read: 388 Downloads: 92 Published: 03 September 2019


Objective: We have conducted this study to evaluate clinical and laboratory findings and to gather and evaluate information that would be useful in clinical practice, such as demographics, joint involvement patterns, laboratory anomalies, treatments applied, and responses obtained in patients diagnosed with gout.


Methods: In our study, the demographic, clinical, and laboratory characteristics of 94 patients diagnosed with gout were evaluated. The patients were re-evaluated with regard to their clinical and laboratory findings at the end of the 1st and 3rd months, their responses to the treatment were observed, and where necessary, new treatment adjustments were made.


Results: Seventy-nine (84%) of the patients were men, and 15 (16%) were women. The ages of the patients ranged between 22 and 86 years with the average age being 57.5 years. The joint involvement during a gouty arthritis attack was most frequently observed in the 1st metatarsophalangeal joint (87.2%), followed by the ankle joint (26.9%), and the knee joint (23.7%). The joint involvement pattern was evaluated to reveal that the acute monoarticular arthritis was observed in 87 patients (93.5%), followed by acute oligoarticular arthritis coming in second in terms of frequency (26.9%). An average attack was determined to last 10.7 days, and the average number of attacks in a year was 2.69. In our study, the colchicine treatment in 24 of our patients, in whom it was determined during the admission and follow-up process that they have not had gouty arthritis attack in the past 3 months, was stopped. Five (20.8%) patients whose colchicine treatment was stopped later developed gouty arthritis attacks, and the colchicine treatment was restarted. On the other hand, 10 out of 38 patients (26.3%), who have either been continuing or had never been on colchicine treatment, were observed to experience a gouty arthritis attack during their 1st and 3rd month check-ups.


Conclusion: In patients with gout, it is recommended that the related diseases, as well as the triggering factors (alcohol, drug use, and dietary effect), be determined, the necessary lifestyle changes be made, and the treatments started.


Cite this article as: Özdem İnan Y, Alpay Kanıtez N, Çelik S, Yılmaz Öner S, Yılmazer B, Bes C. Demographic, clinical, and laboratory features of Turkish patients with gouty arthritis: A prospective cohort study. Eur J Rheumatol 2019; 6(1): 1-6.

ISSN2147-9720 EISSN 2148-4279